Capricor Therapeutics (CAPR) Receivables (2012 - 2025)
Capricor Therapeutics' (CAPR) quarterly Receivables came in at $59167.0 in Q3 2025, down 85.56% year-on-year from $409682.0 in Q3 2024, and down 0.57% quarter-over-quarter from $59509.0 in Q2 2025.
Capricor Therapeutics (CAPR) Receivables (2012 - 2025) Analysis & Trends
Capricor Therapeutics' Receivables history runs 14 years deep, the most recent figure standing at $59167.0 for Q3 2025.
- On a quarterly basis, Receivables fell 85.56% year-over-year to $59167.0 in Q3 2025; TTM through Sep 2025 was $59167.0, a 85.56% decrease from a year earlier, with the FY2025 full-year figure at $59167.0, down 99.71% from the prior year.
- Receivables declined to $59167.0 in Q3 2025 per CAPR's latest filing, from $59509.0 in the prior quarter.
- Across five years, Receivables topped out at $20.4 million in Q4 2024 and bottomed at $59167.0 in Q3 2025.
- The 5-year median for Receivables is $409682.0 (2024), against an average of $2.7 million.
- Across the five-year window, Receivables soared 3552.43% in 2023 and sank 85.56% in 2025, its largest moves.
- Year by year, Receivables stood at $391750.0 in 2021, then soared by 39.78% to $547580.0 in 2022, then surged by 3552.43% to $20.0 million in 2023, then grew by 1.84% to $20.4 million in 2024, then slumped by 99.71% to $59167.0 in 2025.
- Per Business Quant, the three latest CAPR Receivables figures stand at $59167.0 (Q3 2025), $59509.0 (Q2 2025), and $59834.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Capricor Therapeutics | 457.86 Mn | 457.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 59,167.00 |
| Jun 30, 2025 | 59,509.00 |
| Mar 31, 2025 | 59,834.00 |
| Dec 31, 2024 | 20.37 Mn |
| Sep 30, 2024 | 409,682.00 |
| Jun 30, 2024 | 369,975.00 |
| Mar 31, 2024 | 369,000.00 |
| Dec 31, 2023 | 20.00 Mn |
| Sep 30, 2023 | 547,580.00 |
| Jun 30, 2023 | 547,580.00 |
| Mar 31, 2023 | 547,580.00 |
| Dec 31, 2022 | 547,580.00 |
| Sep 30, 2022 | 547,580.00 |
| Jun 30, 2022 | 547,580.00 |
| Mar 31, 2022 | 356,997.00 |
| Dec 31, 2021 | 391,750.00 |
| Sep 30, 2021 | 180,178.00 |
| Dec 31, 2020 | 56,000.00 |
| Sep 30, 2020 | 16,863.00 |
| Jun 30, 2020 | 50,249.00 |